Arbro Pharmaceuticals has launched SNEC30, a patented highly bioavailable self-nanoemulsifying curcumin formulation in the dosage of 30mg. Clinical research conducted over the last 25 years has shown ...
TOKYO, Nov. 25, 2014 /PRNewswrie/ -- Theravalues Corporation is proud to announce the launching of Theracurmin® Super for the European market at Hi Europe 2014 (Dec. 2-4, Amsterdam). It is the highest ...
Postoperative radiotherapy for gallbladder cancer. This is an ASCO Meeting Abstract from the 2013 Gastrointestinal Cancers Symposium. This abstract does not include a full text component.
Partners with Jamia Hamdard University to carry out research to develop a novel formulation which can overcome curcumin’s poor bio availability Arbro Pharmaceuticals has launched SNEC30, a patented ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback